On the other hand, except for COL3A1 that correlated with worse RFS in all BC subtypes, all the ligands that bind NK-inhibitory receptors were associated with better RFS mainly in a subtype-independent manner (Table 2). This evidence concerns the gene COL3A1 and breast cancer.